A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Theriau, Christopher F.
Feng, Jamie
Eng, Lawson
Shepherd, Frances A.
DeCarolis, Mary
Glenns, Vivian
Kulkarni, Swati
VanderMeer, Rachel
Zurawska-Fortin, Urszula
Hao, Desiree
Le, Lisa
Wozniczka, Isabel
Al-Kindy, Aida
Xie, Danny
Zhang, Tong
Subramanian, Vasanth
Stockley, Tracy
Bradbury, Penelope A.
Liu, Geoffrey
Leighl, Natasha B.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT206
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT206
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Zullo, L.
    Cella, E.
    Paoloni, F.
    Gualtieri, M.
    Barletta, G.
    Favero, D.
    Parisi, F.
    Dellepiane, C.
    Rossi, G.
    Bennicelli, E.
    Zinoli, L.
    Cantini, L.
    Pecci, F.
    Del Mastro, L.
    Berardi, R.
    Genova, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S78 - S79
  • [32] A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
    Morse, MA
    Garst, J
    Osada, T
    Khan, S
    Hobeika, A
    Clay, TM
    Valente, N
    Shreeniwas, R
    Sutton, MA
    Delcayre, A
    Hsu, DH
    Le Pecq, JB
    Lyerly, HK
    JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
  • [33] Phase I study of ridaforolimus with cetuximab for patients with advanced non-small cell lung cancer (NSCLC), colorectal cancer, and head and neck cancer
    Taber, Angela Marie
    Khurshid, Humera
    Perez, Kimberly
    Birnbaum, Ariel E.
    Olszewski, Adam J.
    Luppe, Denise
    Jean, Maureen
    Rosati, Kayla
    Safran, Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Phase II study of paclitaxel (Genaxol®) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)
    Chen, CH
    Chang, WC
    Lin, MC
    Hsu, JW
    Chao, TY
    Tsao, TCY
    LUNG CANCER, 2002, 38 (01) : 91 - 96
  • [35] Sunitinib in Combination With Erlotinib for the Treatment of Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC): a Phase III Study
    Govindan, R.
    Krzakowski, M. J.
    Szczesna, A.
    Strausz, J.
    Makhson, A. N.
    Reck, M.
    Tye, L.
    Zhang, K.
    Chao, R. C.
    Scagliotti, G. V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S557 - S557
  • [36] BIOMARKER DEVELOPMENT FOR A PHASE II STUDY OF COMBINATION EPIGENETIC THERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wrangle, John M.
    Juergens, Rosalyn A.
    Vendetti, Frank
    Coleman, Barbara
    Sebree, Rosa
    Rudek, Michelle
    Herman, James
    Rudin, Charles
    Brock, Malcolm V.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1101 - S1101
  • [37] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [38] Phase II study of Docetaxel (D) and Carboplatin (C) combination in advanced Non-Small Cell Lung Cancer (NSCLC)
    Chowdhury, Qamruzzaman
    Begum, Ferdous A.
    Nahar, Ferdous
    Fairuz, Saima
    Faruqui, Mesba
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S673 - S673
  • [39] A phase II study of multikinase inhibitor sorafenib in patients with relapsed non-small cell lung cancer (NSCLC)
    Gutierrez, M.
    Kummar, S.
    Allen, D.
    Turkbey, B.
    Choyke, P.
    Wright, J. J.
    Kurkjian, C.
    Giaccone, G.
    Doroshow, J. H.
    Murgo, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Advanced non-small cell lung cancer - Treatment with Pembrolizumab
    Silvinato, Antonio
    Floriono, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1423 - 1432
12345